Renown Institute for Heart & Vascular Health (Site 1055) — Reno, Nevada

Renown Institute for Heart & Vascular Health (Site 1055) is a clinical research site located in Reno, Nevada, United States 89502-1262.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Renown Institute for Heart & Vascular Health (Site 1055) has participated in 1 clinical trials.

Therapeutic areas: Pulmonary Arterial Hypertension.

Sponsors: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Renown Institute for Heart & Vascular Health (Site 1055)?

Renown Institute for Heart & Vascular Health (Site 1055) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Renown Institute for Heart & Vascular Health (Site 1055) conducted?

Renown Institute for Heart & Vascular Health (Site 1055) has 1 clinical trials on record. Their work covers Pulmonary Arterial Hypertension.

Is Renown Institute for Heart & Vascular Health (Site 1055) accredited by Crixeo Health?

Renown Institute for Heart & Vascular Health (Site 1055) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Renown Institute for Heart & Vascular Health (Site 1055)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.